Janus Henderson Group PLC Sarepta Therapeutics, Inc. Transaction History
Janus Henderson Group PLC
- $178 Billion
- Q1 2024
A detailed history of Janus Henderson Group PLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 4,891,417 shares of SRPT stock, worth $773 Million. This represents 0.36% of its overall portfolio holdings.
Number of Shares
4,891,417
Previous 5,345,785
8.5%
Holding current value
$773 Million
Previous $515 Million
22.84%
% of portfolio
0.36%
Previous 0.32%
Shares
24 transactions
Others Institutions Holding SRPT
# of Institutions
470Shares Held
79.3MCall Options Held
4.23MPut Options Held
1.21M-
Vanguard Group Inc Valley Forge, PA8.8MShares$1.39 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.96MShares$942 Million0.02% of portfolio
-
Capital International Investors Los Angeles, CA4.82MShares$761 Million0.13% of portfolio
-
Avoro Capital Advisors LLC New York, NY4.34MShares$686 Million6.78% of portfolio
-
Wellington Management Group LLP Boston, MA3.25MShares$513 Million0.08% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $13.8B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...